Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 01/28/2026 | Q4 | $22.4B | -- | -- | -$0.41 | -- |
| 10/29/2025 | Q3 | $22.1B | $23.3B | -$7.14 | -$2.38 | -$4.76 |
| 07/29/2025 | Q2 | $21.6B | $22.7B | -$0.92 | -$1.27 | $0.35 |
| 04/23/2025 | Q1 | $19.8B | $19.5B | -$0.16 | -$1.30 | $1.14 |
| 01/28/2025 | Q4 | $15.2B | $15.2B | -$5.46 | -$3.78 | -$1.68 |
| 10/23/2024 | Q3 | $17.9B | $17.8B | -$9.97 | -$8.72 | -$1.25 |
| 07/31/2024 | Q2 | $17.3B | $16.9B | -$2.33 | -$2.01 | -$0.32 |
| 04/24/2024 | Q1 | $17B | $16.6B | -$0.56 | -$1.52 | $0.96 |
| 01/31/2024 | Q4 | $21.1B | $22B | -$0.04 | -$0.79 | $0.75 |
| 10/25/2023 | Q3 | $18.3B | $18.1B | -$2.70 | -$2.61 | -$0.09 |
| 07/26/2023 | Q2 | -- | $19.8B | -$0.25 | -- | -- |
| 04/26/2023 | Q1 | -- | $17.9B | -$0.69 | -- | -- |
| 01/25/2023 | Q4 | -- | $20B | -$1.06 | -- | -- |
| 10/26/2022 | Q3 | -- | $16B | -$5.50 | -- | -- |
| 07/27/2022 | Q2 | -- | $16.7B | $0.32 | -- | -- |
| 04/27/2022 | Q1 | -- | $14B | -$2.06 | -- | -- |
| 01/26/2022 | Q4 | -- | $14.8B | -$7.02 | -- | -- |
| 10/27/2021 | Q3 | -- | $15.3B | -$0.19 | -- | -- |
| 07/28/2021 | Q2 | -- | $17B | $1.00 | -- | -- |
| 04/28/2021 | Q1 | -- | $15.2B | -$0.92 | -- | -- |
| 01/27/2021 | Q4 | -- | $15.3B | -$14.65 | -- | -- |
| 10/28/2020 | Q3 | -- | $14.1B | -$0.79 | -- | -- |
| 07/29/2020 | Q2 | -- | $11.8B | -$4.20 | -- | -- |
| 04/29/2020 | Q1 | -- | $16.9B | -$1.11 | -- | -- |
| 01/29/2020 | Q4 | -- | $17.9B | -$1.79 | -- | -- |
| 10/23/2019 | Q3 | -- | $20B | $2.05 | -- | -- |
| 07/24/2019 | Q2 | -- | $15.8B | -$5.21 | -- | -- |
| 04/24/2019 | Q1 | -- | $22.9B | $3.75 | -- | -- |
| 01/30/2019 | Q4 | -- | $28.3B | $5.93 | -- | -- |
| 10/24/2018 | Q3 | -- | $25.1B | $4.07 | -- | -- |
| 07/25/2018 | Q2 | -- | $24.3B | $3.73 | -- | -- |
| 04/25/2018 | Q1 | -- | $23.4B | $4.15 | -- | -- |
| 01/31/2018 | Q4 | -- | $25.4B | $5.17 | -- | -- |
| 10/25/2017 | Q3 | -- | $24.2B | $2.99 | -- | -- |
| 07/26/2017 | Q2 | -- | $23.1B | $2.87 | -- | -- |
| 04/26/2017 | Q1 | -- | $22B | $2.54 | -- | -- |
| 01/25/2017 | Q4 | -- | $23.3B | $2.59 | -- | -- |
| 10/26/2016 | Q3 | -- | $23.9B | $3.60 | -- | -- |
| 07/27/2016 | Q2 | -- | $24.8B | -$0.37 | -- | -- |
| 04/27/2016 | Q1 | -- | $22.6B | $1.83 | -- | -- |
| 01/27/2016 | Q4 | -- | $23.6B | $1.51 | -- | -- |
The Boeing Co. reported $23.3B worth of top line sales in its most recent quarter.
The Boeing Co. announced earnings per share of -$7.14 which represents a miss of analyst forecast a -$2.38 per share.
The Boeing Co. reported -$2.4B that represents -$3.11 per share over the last quarter.
The Boeing Co.'s earnings are forecast to decrease from -$18.36 per share to -$19.57 per share next year representing a decrease of -47.57%.
The Boeing Co.'s next earnings date is January 28, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.